缺血预处理在肾移植缺血再灌注中的研究进展
Research Progress of Ischemic Preconditioning with Ischemia Reperfusion Injury of Renal Transplantation
摘要: 器官获取与移植不可避免面对缺血再灌注损伤,引起细胞内环境改变、炎症反应、活性氧聚集等,影响移植物功能延迟恢复及远期移植器官结局。尽管现阶段有较多研究改善缺血再灌注损伤,使得器官移植1年存活率有所提高,但近年来移植物的长期存活率并没有显著改变。从Murry等人在1986年发现缺血预处理(IPC)对器官移植的潜在益处后,在心脏保护方面取得显著成绩,其他证据表明在肾移植中也有明显效果。缺血预处理通过激活短暂非致死性缺氧环境,体液通讯、神经元刺激、循环免疫细胞的系统修饰和低氧诱导基因的激活保护机体免受更长时间的潜在致死性缺血。本文主要介绍缺血预处理的相关机制。
Abstract: Organ acquisition and transplantation inevitably face ischemia-reperfusion injury, causing intra-cellular environment changes, inflammatory response, reactive oxygen species accumulation, etc., affecting the delayed recovery of graft function and long-term outcomes of transplanted organs. Although there are many studies at present to improve the 1-year survival rate of organ transplan-tation after ischemia reperfusion injury, the long-term survival rate of grafts has not changed sig-nificantly in recent years. Since the discovery by Murry et al. in 1986 of the potential benefits of is-chaemic preconditioning (IPC) for organ transplantation with significant results in cardio protection, and other evidence has shown that it also has significant effects in kidney transplantation, ischemic preconditioning protects the organism from potentially lethal ischemia of longer duration by acti-vating a transient nonlethal hypoxic environment, humoral communication, neuronal stimulation, systemic modification of circulating immune cells, and activation of hypoxia inducible genes. This review focuses on the mechanisms involved in ischemic preconditioning.
文章引用:钟明轩, 张克勤. 缺血预处理在肾移植缺血再灌注中的研究进展[J]. 临床医学进展, 2023, 13(3): 4942-4947. https://doi.org/10.12677/ACM.2023.133705

参考文献

[1] Zhao, H., et al. (2018) Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond. EBioMedicine, 28, 31-42. [Google Scholar] [CrossRef] [PubMed]
[2] Yan, H.F., et al. (2020) The Patholog-ical Role of Ferroptosis in Ischemia/Reperfusion-Related Injury. Zoological Research, 41, 220-230. [Google Scholar] [CrossRef] [PubMed]
[3] Shelke, V., et al. (2022) Epigenetic Regulation of Toll-Like Receptors 2 and 4 in Kidney Disease. Journal of Molecular Medicine (Berlin), 100, 1017-1026. [Google Scholar] [CrossRef] [PubMed]
[4] DeWolf, S.E., et al. (2022) DAMPs Released from Injured Re-nal Tubular Epithelial Cells Activate Innate Immune Signals in Healthy Renal Tubular Epithelial Cells. Transplantation, 106, 1589-1599. [Google Scholar] [CrossRef
[5] Li, L. and Okusa, M.D. (2010) Macrophages, Dendritic Cells, and Kidney Ischemia-Reperfusion Injury. Seminars in Nephrology, 30, 268-277. [Google Scholar] [CrossRef] [PubMed]
[6] Barbi, J., Pardoll, D. and Pan, F. (2013) Metabolic Control of the Treg/Th17 Axis. Immunological Reviews, 252, 52-77. [Google Scholar] [CrossRef] [PubMed]
[7] Fuquay, R., et al. (2013) Renal Ischemia-Reperfusion Injury Amplifies the Humoral Immune Response. Journal of the American Society of Nephrology, 24, 1063-1072. [Google Scholar] [CrossRef
[8] Liu, Y. (2011) Cellular and Molecular Mechanisms of Renal Fibro-sis. Nature Reviews Nephrology, 7, 684-696. [Google Scholar] [CrossRef] [PubMed]
[9] Legrand, M., et al. (2008) Renal Hypoxia and Dysoxia after Reper-fusion of the Ischemic Kidney. Molecular Medicine, 14, 502-516. [Google Scholar] [CrossRef
[10] Veighey, K. and MacAllister, R. (2015) Clinical Applications of Remote Ischaemic Preconditioning in Native and Transplant Acute Kidney Injury. Pediatric Nephrology, 30, 1749-1759. [Google Scholar] [CrossRef] [PubMed]
[11] Yellon, D.M. and Downey, J.M. (2003) Preconditioning the My-ocardium: From Cellular Physiology to Clinical Cardiology. Physiological Reviews, 83, 1113-1151. [Google Scholar] [CrossRef] [PubMed]
[12] Bruzzese, L., et al. (2021) Hypoxic Preconditioning in Renal Is-chaemia-Reperfusion Injury: A Review in Pre-Clinical Models. Clinical Science (London), 135, 2607-2618. [Google Scholar] [CrossRef
[13] Guieu, R., et al. (2020) Adenosine and the Cardiovascular System: The Good and the Bad. Journal of Clinical Medicine, 9, 1366. [Google Scholar] [CrossRef] [PubMed]
[14] Kellenberger, T., et al. (2015) Expression of Hypoxia-Inducible Factor-1α and Hepatocyte Growth Factor in Development of Fibrosis in the Transplanted Kidney. Transplant International, 28, 180-190. [Google Scholar] [CrossRef] [PubMed]
[15] Delpech, P.O., et al. (2014) Effects of Warm Ischaemia Combined with Cold Preservation on the Hypoxia-Inducible Factor 1α Pathway in an Experimental Renal Autotransplantation Model. British Journal of Surgery, 101, 1739-1750. [Google Scholar] [CrossRef] [PubMed]
[16] Kharechkina, E.S., et al. (2021) Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition. Pharmaceuticals (Basel), 14, 1045. [Google Scholar] [CrossRef] [PubMed]
[17] Randhawa, P.K., Bali, A. and Jaggi, A.S. (2015) RIPC for Multiorgan Salvage in Clinical Settings: Evolution of Concept, Evidences and Mechanisms. European Journal of Pharmacology, 746, 317-332. [Google Scholar] [CrossRef] [PubMed]
[18] Ho, J., et al. (2008) Podocyte-Specific Loss of Functional mi-croRNAs Leads to Rapid Glomerular and Tubular Injury. Journal of the American Society of Nephrology, 19, 2069-2075. [Google Scholar] [CrossRef
[19] Xu, X., et al. (2012) Delayed Ischemic Preconditioning Contributes to Renal Protection by Upregulation of miR-21. Kidney International, 82, 1167-1175. [Google Scholar] [CrossRef] [PubMed]
[20] Ghafouri-Fard, S., et al. (2021) Regulatory Role of microRNAs on PTEN Signaling. Biomedicine & Pharmacotherapy, 133, Article ID: 110986. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, Z. and Gong, R. (2015) Remote Ischemic Preconditioning for Kidney Protection: GSK3β-Centric Insights into the Mechanism of Action. American Journal of Kidney Diseases, 66, 846-856. [Google Scholar] [CrossRef] [PubMed]
[22] Crowley, L.E. and McIntyre, C.W. (2013) Remote Is-chaemic Conditioning-Therapeutic Opportunities in Renal Medicine. Nature Reviews Nephrology, 9, 739-746. [Google Scholar] [CrossRef] [PubMed]
[23] Rossaint, J., et al. (2022) Remote Ischemic Preconditioning Causes Transient Cell Cycle Arrest and Renal Protection by a NF-κB-Dependent Sema5B Pathway. JCI Insight, 7, e158523. [Google Scholar] [CrossRef] [PubMed]
[24] Ong, S.B., et al. (2015) Role of the MPTP in Conditioning the Heart-Translatability and Mechanism. British Journal of Pharmacology, 172, 2074-2084. [Google Scholar] [CrossRef] [PubMed]
[25] Cohen, M.V., et al. (2001) Acetylcholine, Bradykinin, Opioids, and Phe-nylephrine, but Not Adenosine, Trigger Preconditioning by Generating Free Radicals and Opening Mitochondrial K(ATP) Channels. Circulation Research, 89, 273-278. [Google Scholar] [CrossRef] [PubMed]